The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
low-grade squamous intraepithelial lesion (LSIL)
Funded by
affordable
Collaborating Institutions
and high-grade squamous intraepithelial lesion (HSIL). This Molecular Pap may circumvent the resource and expertise challenges of cytology-based screening programs. Such an automated
computerized test possesses tremendous practical value in several respects: 1) increased throughput and accuracy
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
and HSIL. Secondly
Collaborating Institutions
we intend to compare the clinical performance of the Molecular Pap to current cervical cancer screening (traditional Pap +/- cobas® hrHPV) in a head-to-head challenge to continue the development of this molecular diagnostic.
The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.
Principal Investigator(s)
Forsthuber, Thomas
Funded by
Natl Inst of Health
B cell-depleting therapies using anti-CD20 monoclonal antibodies have been successful for the treatment of relapsing-remitting multiple sclerosis (RRMS); however, B cell-depletion showed incomplete efficacy for the treatment of autoantibody-mediated autoimmune conditions, including Systemic Lupus Erythematosus (SLE) and neuromyelitis optica (NMO), most likely because of the failure to eliminate autoantibody-producing long-lived plasma cells (PCs).
